CD40 ligand expression in mycosis fungoides is restricted to the patch/plaque (epidermotropic) stages

European Journal of Dermatology

Volumn 7, Issue 8, 1997, Pages 556-560

  Mori, Moira ^a   Manuelli, Cinzia ^a   Pimpinelli, Nicola ^a   Mavilia, Carmelo ^a   Bianchi, Beatrice ^a   Santucci, Marco ^a   Giannotti, Benvenuto ^a   Cappugi, Pietro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CD40 ligand; Cutaneous T cell lymphoma; Mycosis fungoides

Indexed keywords

CD40 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER RISK; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MYCOSIS FUNGOIDES; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0031438750     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Alderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Sprigg MK. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80-7.
2. Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA. Cloning of TRAP, a ligand for CD40 on human T-cells. Eur J Immunol 1992; 22: 3191-9.
3. Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligand. Curr Opin Immunol 1994; 6: 407-13.
4. Lane P, Brocker T, Hubele S, Padovan E, Lanzavecchia A, McConnell F. Soluble CD40 ligand can replace the normal T-cell derived CD40 ligand signal to B-cells in T-cell-dependent activation. J Exp Med 1993; 177: 1209-17.
5. Galy AHM, Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992; 149: 775-81.
6. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Sprigg MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669-75.
7. Gruss H, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378-404.
8. Hollenbaugh D, Mischel Pett N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A. Expression of functional CD40 by vascular endothelial cells J Exp Med 1995; 182: 33-40.
9. Yellin M, Brett J, Baum D, Matsuhima A, Szabolcs M, Stern D, Chess L. Functional interactions of T-cells with endothelial cells: the role of CD40-CD40L-mediated signals. J Exp Med 1995; 182: 1857-64.
10. Lotz M, Setareh M, von Kempis J, Schwarz H. The nerve growth factor/tumor necrosis factor receptor family. J Leuk Biol 1996; 60: 1-7.
11. Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996; 17: 478-83.
12. Grewal IS, Flavell RA. The CD40 ligand at the center of the immune universe? Immunol Res 1997; 16: 59-70.
13. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S. The CD40 antigen and its ligand. Ann Rev Immunol 1994; 12: 881-922.
14. Schultze JL, Cardoso AA, Freeman GJ, Seamon MJ, Daley J, Pinkus GS, Gribben JG, Nadler LM. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. PNAS 1995; 92: 8200-4.
15. Armitage RJ, Tough TW, Macduff BM, Fanlow WC, Spriggs MK, Ramsdell F, Alderson MR. CD40 ligand is a T-cell growth factor. Eur J Immunol 1993; 22: 2326-31.
16. Carbone A, Gloghini A, Gruss HJ, Pinto A. CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147: 12-22, 1995.
17. Pimpinelli N, Santucci M, Giannotti B. Cutaneous lymphoma: a clinically relevant classification. Int J Dermatol 1993; 32: 695-700.
18. Willemze R. Classification of primary cutaneous lymphomas. Historical overview and perspectives. Dermatology 1994; 189: 8-15.
19. Willemze R, Beljaards R, Meijer CJLM. Classification of primary CTCL Histopathology 1994; 74: 407-15.
20. Cordell JL, Folini B, Erber WN, Stein H, Mason DY. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes) J Histochem Cytochem 1984; 32: 219-26.
21. Southern EM. Detection of specific sequence among DNA fragments by gel electrophoresis. J Mol Biol 1975; 98: 503-17.
22. Hollenbaugh D, Gosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter J, Aruffo A. The human T-cell antigen gp39, a member of TNF gene family, is a ligand for CD40 receptor: expression of soluble form of gp39 with B-cell co-stimulatory activity EMBO 1992; 11: 4313-21.
23. Santucci M. Cutaneous T-cell lymphoma: clues to diagnosis in early lesions. In: Vloten WA van, Lambert WC, Giannotti B, eds. Basic mechanisms of physiological and aberrant lymphoproliferation in the skin. (NATO ASI Series A; Life Science.) New York: Plenum Press, 1994: 243-54.
24. Fivenson DP, Hanson AH, Nickoloff BJ. Localization of clonal T-cells to the epidermis in cutaneous T-cell lymphoma. J Am Acad Dermatol 1994; 31: 717-23.
25. Mielke V, Staig G, Boehncke WH, Duller B, Sterry W. Clonal disease in early cutaneous T-cell lymphoma. In: Burg G, Kerl H, Thiers B, eds. Dermatologic Clinics. Cutaneous lymphomas. Saunders Co. Philadelphia, PA, 1994; 12 (suppl. 2): 351-60.
26. Fivenson DP, Rheins LA, Nordlund JJ. Thy-1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermatoses J Natl Cancer Inst 1991; 83: 1088-93.
27. Fivenson DP, Douglass MC, Nickoloff BJ. Cutaneous expression of Thy-1 in mycosis Fungoides. Am J Pathol 1992; 141: 1373-9.
28. Rook AH, Vowels BR, Jaworsky. The immunopathogenesis of cutaneous T-cell lymphoma. Arch Dermatol 1993; 129: 486-91.
29. Caux C, Massacrier C, Vanbervliet B, Dubois B, van Kooten C, Durand I, Blancherau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180: 1263-72.
30. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α but strongly enhanced by interleukin-10. Eur J Immunol 1995; 25: 1943-50.
31. Peguet-Navarro J, Dalbiez-Guathier C, Rattis FM, Van Kooten C, Banchereau J, Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 1995; 155: 4241-7.
32. Bani D, Moretti S, Pimpinelli N, Giannotti B. Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study. Virchows Arch A (Pathol Anat Histopathol) 1988; 412: 451-7.
33. Pimpinelli N, Santucci M, Romagnoli P, Giannotti B. Dendritic cells in T-and B-cell proliferation in the skin. In: Dermatologic Clinics. Cutaneous lymphomas. Burg G., Kerl H., Thiers B., eds. Saunders Co., Philadelphia, USA, 1994; 12 (suppl. 2): 255-70.
34. Pimpinelli N, Romagnoli P, Santucci M, Giannotti B. Morpho-antigenic features of dendritic cells as a clue to the interpretation of skin immune system-related disorders. In: Vloten WA van, Lambert WC, Giannotti B, eds. Basic mechanisms of physiological and aberrant lymphoproliferation in the skin. (NATO ASI Series; Serie A; Life Science.) New York: Plenum Press, 1994: 57-76.